ロード中...

NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes

Increasing evidence suggests that NODs are involved in liver diseases; however, the underlying mechanisms remain obscure. In the present study, we analyzed the effect of NOD1 agonist pretreatment on acute liver failure induced by lipopolysaccharide (LPS) in D-galactosamine (D-GalN)-sensitized mice....

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Jia, Fang, Deng, Fuxue, Xu, Pan, Li, Shiying, Wang, Xuefu, Hu, Peng, Ren, Hong, Tong, Shiwen, Yin, Wenwei
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7969647/
https://ncbi.nlm.nih.gov/pubmed/33746949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.603192
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!